Imaging Genetics of Brain Longevity and Mental Wellness: The Next Frontier?
![]() Effect of APOE4 allele on glucose metabolism in young adults. Image illustrates regions of the brain with abnormally low glucose metabolism measured at FDG PET in young adult carriers of APOE4 allele in relation to those of patients with probable Alzheimer disease (AD). 3D surface-projection map of abnormally low glucose metabolism in young adult 4 carriers is superimposed on a map of abnormally low glucose metabolism in previously studied patients with probable AD. (Reprinted, with permission, from Reiman E.M., Chen K., Alexander G.E., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci USA 2004;101:284–289). (Radiology 2008;246:20–32) © RSNA, 2008. All rights reserved. Printed with permission. |
Nearly two-thirds of the approximately 30,000 genes in the human genome are related to brain function and up to half the variance in age-related changes in cognition, brain volume and neuronal function appears to be genetically determined. As neuroimaging is employed to study the effects of genes, neurogenetics may affect future radiology research and practice.
In a review article in the January issue of Radiology (RSNA.org/radiology), Jeffrey R. Petrella, M.D., Venkata S. Mattay, M.D., and P. Murali Doraiswamy, M.D., of Duke University Medical Center review the basic principles of imaging genetics. They also summarize genetic polymorphisms that may potentially affect brain aging and use specific polymorphisms to illustrate how genetic-imaging findings are evolving and may affect radiology.
Specifically, the researchers address:
• Genomics, proteomics and metabolomics of brain function
• Genes and brain longevity
• Apolipoprotein E (APOE) gene
• Genes regulating neurotransmitter enzymes or receptors
• Genes regulating neuronal growth factors
As technology advances, public interest in genotyping will continue to grow, according to the researchers, who note the confidential genotyping services becoming available commercially via the Internet. The researchers add, however, that physicians should be wary of rushing to adopt new technology until appropriate sensitivity and specificity studies are conducted and genomics can be shown to improve patient outcomes above and beyond currently available clinical measures.
"Until then, imaging-genetics correlative studies will remain a useful research tool to enhance our knowledge of the aging and diseased brain," the researchers conclude.
To access this Radiology article now, click here.



